minimal residual disease
The rate of patients with negative minimal residual disease (MRD) after induction was 60%, with the group of patients who received Imatinib achieving a better rate of MRD negativity than those who did not (p=0,001).
The rate of patients with negative minimal residual disease ( MRD ) after induction was 60%, with the group of patients who received Imatinib achieving a better rate of MRD negativity than those who did not ( p=0,001 ) .